REFERENCES
- Borak J., Diller W. F. Phosgene exposure: Mechanisms of injury and treatment strategies. J. Occup. Environ. Med. 2001; 43: 110–119
- Boscoe M. J., Goodwin A. T., Amrani M., Yacoub M. H. Endothelins and the lung. Int. J. Biochem. Cell Biol. 2000; 32: 41–62
- Breier G., Albrecht U., Sterrer S., Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521–532
- Clerico A., Del Chicca M. G., Zucchelli G. C., Biver P., Mariani G., Bertelli A., Bertelli A. A. Critical evaluation of endothelins assay. Int. J. Tissue React. 1994; 16: 79–87
- Corne J., Chupp G., Lee C. G., Homer R. J., Zhu Z., Chen Q., Ma B., Du Y., Roux F., McArdle J., Waxman A. B., Elias J. A. IL-13 stimulates vascular endothelial cell growth factor and protects against hyperoxic acute lung injury. J. Clin. Invest. 2000; 106: 783–791
- de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc. Natl. Acad. Sci. USA 1998; 85: 9797–9800
- Diller W. F., Schnellbaecher F., Wuestefeld E. Pulmonale spaetfolgen nach phosgenvergiftungbzw. Inhalationstoxischem lungenoedem [Late pulmonary sequelae of phosgene poisoning or inhalation-toxic pulmonary edema]. Zentralbl. Arbeitsmed. Arbeitsschutz. Prophyl. 1979; 29: 5–16
- Doggenweiler C. F., Frenk S. Staining properties of lanthanum on cell membranes. Proc. Natl. Acad. Sci. USA 1965; 53: 425–427
- Dupuis J., Cernacek P., Tardif J. C., Stewart D. J., Gosselin G., Dyrda I., Bonan R., Crepeau J. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am. Heart J. 1998; 135: 614–620
- Ricciardolo F. L., Sterk P. J., Gaston B., Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004; 84: 731–765
- Faraone S., Alifano M., Maniscalco M., Micco A., Gravino E., Lanza A. Urinary endothelin excretion in patients with acute lung injury. Monaldi Arch. Chest Dis. 1997; 52: 217–220
- Ferrara N., Gerber H. P., Le Couter J. The biology of VEGF and its receptors. Nat. Med. 2003; 9: 669–676
- Houck K. A., Ferrara N., Winer J., Cachianes G., Li B., Leung D. W. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 1991; 5: 1806–1814
- Ishii H., Oota I., Arakawa T., Takuma T. Differential gene expression of vascular endothelial growth factor isoforms and their receptors in the development of the rat masseter muscle. Arch. Oral Biol. 2002; 47: 505–510
- Ito Y., Betsuyaku T., Nagai K., Nasuhara Y., Nishimura M. Expression of pulmonary VEGF family declines with age and is further down-regulated in lipopolysaccharide (LPS)-induced lung injury. Exp. Gerontol. 2005; 40: 315–323
- Jian M. Y., Koizumi T., Kubo K. Effects of nitric oxide synthase inhibitor on acid aspiration-induced lung injury in rats. Pulmon. Pharmacol. Ther. 2005; 18: 33–39
- Kaner R. J., Ladetto J. V., Singh R., Fukuda N., Matthay M. A., Crystal R. G. Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am. J. Respir. Cell Mol. Biol. 2000; 22: 657–664
- Karmpaliotis D., Kosmidou I., Ingenito E. P., Hong K., Malhotra A., Sunday M. E., Haley K. J. Angiogenic growth factors in the pathophysiology of a murine model of acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2002; 283: L585–L595
- Levin E. R. Mechanisms of disease: endothelins. N. Engl. J. Med. 1995; 333: 356–363
- Li W. L., Hai C. X., Liang X., Zhang X. D., Chen H. L., Qin X. J., Liu R., He W., Wang P., Li B. Apoptosis of ATII cells in mice induced by phosgene. Inhal. Toxicol. 2006; 18: 71–77
- Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 1951; 193: 265–275
- Maitre B., Boussat S., Jean D., Gouge M., Brochard L., Housset B., Adnot S., Delclaux C. Vascular endothelial growth factor synthesis in the acute phase of experimental and clinical lung injury. J. Eur. Respir. 2001; 18: 100–106
- National Toxicology Program. Chemical health and safety data. 2001, http://ntp-server.niehs.nih.gov/Main_Pages/Chem-HS.html
- Neufeld G., Cohen T., Gengrinovitch S., Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13: 9–22
- Newby D. E., Wright R. A., Labinjoh C., Ludlam C. A., Fox K. A., Boon N. A., Webb D. J. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: A mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999; 99: 1411–1415
- Nishikawa S., Miyamoto A., Yamamoto H., Ohshika H., Kudo R. The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci. 2000; 67: 1447–1454
- Punyadeera C., Thijssen V. L., Tchaikovski S., Kamps R., Delvoux B., Dunselman G. A. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Mol. Hum. Reprod. 2006; 12: 367–375
- Rattan S. I. Synthesis, modifications, and turnover of proteins during aging. Exp. Gerontol. 1996; 31: 33–47
- Rees D. D., Palmer R. M., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA 1989; 86: 3375–3378
- Reihill J. A., Ewart M. A., Hardie D. G., Salt I. P. AMP-activated protein kinase mediates VEGF-stimulated endothelial NO production. Biochem. Biophys. Res. Commun. 2007; 354: 1084–1088
- Sakai T., Ishizaki T., Nakai T., Matsukawa S., Hayakawa M., Ozawa T. Mitochondrial dysfunction in acute lung injury caused by endothelial-1 and leukotoxin. Nippon Kyobu Shikkan Gakkai Zasshi 1996; 34: 843–849
- Sakakibara H., Shiiki Y., Okamoto N. Mass poisonings with phosgene. Shindan Chiryo 1967; 55: 1433–1437
- Sciuto A. M. Assessment of early acute lung injury in rodents exposed to phosgene. Arch. Toxicol. 1998; 72: 283–288
- Sciuto A. M., Cascio M. B., Moran T. S., Forster J. S. The fate of antioxidant enzymes in bronchoalveolar lavage fluid over 7 days in mice with acute lung injury. Inhal. Toxicol. 2003; 15: 675–685
- Stitt A. W., Burke G. A., Chen F., McMullen C. B., Vlassara H. Advanced glycation end-product receptor interactions on microvascular cells occur within caveolin-rich membrane domains. FASEB J. 2000; 14: 2390–2392
- Szinicz L. History of chemical and biological warfare agents. Toxicology 2005; 214: 167–181
- Thickett D. R., Armstrong L., Millar A. B. A role for vascular endothelial growth factor in acute and resolving lung injury. Am. J. Respir. Crit. Care Med. 2002; 166: 1332–1337
- Tischer E., Mitchell R., Hartman T., Silva M., Gospodarowicz D., Fiddes J. C., Abraham J. A. The human gene for vascular endothelial growth factor. J. Biol. Chem. 1991; 266: 11947–11954
- Underhill F. P. The physiology and experimental treatment of poisoning with the lethal war gases. Arch Int Med. 1919; 23: 753–770
- Xiang G., Schinzel R., Simm A., Munch G., Sebekova K., Kasper M., Niwa T., Schmitz C., Heidland A. Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1. Nephrol. Dial. Transplant. 2001; 16: 1562–1569
- Yamanouchi J., Takatori A., Nishida E., Kawamura S., Yoshikawa Y. Expression of lipoprotein receptors in the aortic walls of diabetic APA hamsters. Exp. Anim. 2002; 51: 33–41
- Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415